Ocular Drug Delivery Market Trends, Share and Size

1
Ocular Drug Delivery Market

• Ocular Drug Delivery Market by Technology
  (Topical, Iontophoresis, Ocular Insert Erodible
  and Non-Erodible, Intraocular Implants
  Biodegradable and Non-Biodegradable, In Situ
  Gel Punctal Plugs, and Others), Formulation
  Type (Liposomes Nanoparticles, Solution,
  Emulsion, Suspension, and Ointment), by Disease
  Type (Glaucoma, Diabetic Retinopathy, Dry Eye
  Syndrome, Macular Degeneration, Cataract,
  Diabetic Macular Edema, and Others), and by End
  User (Hospitals, Ophthalmic Clinics, Ambulatory
  Surgical Centers, and Homecare Settings) - Global
  Opportunity Analysis and Industry Forecast,
  2017-2023

2
Introduction
Ocular Drug Delivery Market

• The eye is a very valuable organ that can be
  affected by many diseases. These eye diseases can
  affect the body and the person may also lose
  their vision..
• There are many drug delivery systems available in
  the market to treat these eye diseases.. 
• As a result of efficient protective mechanisms
  of the eye, there are a few ophthalmic drugs
  available in the market. Almost 70 of the eye
  dosage formulations available in the market are
  in the form of eye drops and ointments.

3
Factors Contributing to Market Growth
Ocular Drug Delivery Market

• The low bioavailability of drugs in conventional
  ocular therapies are enhancing the growth of
  ocular drug delivery market.
• Favorable reimbursement policies and rise in
  funding to develop advanced drug delivery systems
  can help boost the market growth.
• Other factors that contribute to market growth
  are
• Increase in the incidence of glaucoma macular
  degeneration.
• Growing demand for targeted ocular drug delivery
  techniques.
• Increase in the number of approvals from
  government regulations for new ocular drug
  delivery techniques.

4
Market Segments
Ocular Drug Delivery Market
5
Leading Players
Ocular Drug Delivery Market

• The leading players in the Ocular Drug Delivery
  Market have adopted key strategies such as
  collaborations, agreement and acquisition to
  expand their market presence.
• Valeant Pharmaceuticals International, Inc.,
  Taiwan Liposome Company, Ltd., Ocular
  Therapeutix, Inc., Graybug Vision Inc., EyeGate
  Pharma, Clearside Biomedical, Inc., Alimera
  Sciences, EyeGate Pharma, Envisia Therapeutics,
  and Allergan, Plc. are the key players in this
  industry.

6
A report titled Ocular Drug Delivery Market -
Opportunities and Forecasts, 2017 2023 has
been recently published by Allied Market
Research. It makes an in-depth analysis of
current trends, drivers, and restraining factors
that affect financial ratios relevant to the
industry. Company profiles for key vendors in
business builds a comprehensive picture of
profitable opportunities from stakeholders
perspective.

• To know more about the Ocular Drug Delivery
  Market - Opportunities and Forecasts, 2017 2023
  report
• https//www.alliedmarketresearch.com/ocular-drug-d
  elivery-market

• Follow us on

Thank You